Reply to: "smoking and NASH: A hidden message from the GREACE trial"

Journal of Hepatology

Volumn 56, Issue 1, 2012, Pages 301-302

  Zein, Claudia O ^a   McCullough, Arthur J ^a   Unalp, Aynur ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; DISEASE ASSOCIATION; DISEASE SEVERITY; HISTOPATHOLOGY; HUMAN; LETTER; LIVER EXAMINATION; LIVER FIBROSIS; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; SMOKING; SMOKING CESSATION;

EID: 83555162620     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2011.06.009     Document Type: Letter

References (3)

1. V.G. Athyros, K. Tziomalos, and D. Gossios Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis Lancet 376 2010 1916 1922
2. A. Suzuki, K. Lindor, and J. St. Saver Effect of changes on body weight and lifestyle in nonalcoholic fatty liver disease J Hepatol 43 2011 1060 1066
3. C.O. Zein, A. Unalp, and R. Colving Smoking and severity of hepatic fibrosis in nonalcoholic fatty liver disease J Hepatol 54 2011 753 759